Comparing kidney safety of two antibiotic combinations
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two common antibiotic combinations to see which one is safer for your kidneys. It uses a special blood test (cystatin-C) alongside standard tests to get a clearer picture of kidney function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are prescribed vancomycin with either piperacillin-tazobactam or meropenem for more than 48 hours.
- You do not have advanced chronic kidney disease or need dialysis.
- You are not pregnant.
- You have not recently had a kidney injury or taken certain other kidney-affecting drugs.
- You are not an organ or stem cell transplant recipient within the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two common antibiotic combinations to see which one is less likely to cause kidney injury in hospitalized patients. You may be eligible if you need treatment with vancomycin plus either piperacillin-tazobactam or cefepime.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
This trial tests whether taking vitamin C and rutin (a plant compound) together can help protect the kidneys from damage caused by the antibiotic vancomycin. It compares this combination to vitamin C alone and to no extra supplement.
This Phase 3 study tests whether melatonin can help protect the kidneys in people who are starting or continuing vancomycin, an antibiotic that can sometimes affect kidney function. If you qualify, you would take melatonin as an added prevention step while you’re on vancomycin.
This study tests whether a medicine called cilastatin can prevent kidney damage caused by certain strong medications. If you are receiving one of these medications and are at risk for kidney injury, this trial may offer protection.
This trial tests a different way of giving vancomycin to children with sepsis to reduce the risk of kidney injury. It compares standard dosing to an approach that adjusts dose based on how the kidneys are working.
Hear when a new Nephrotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.